Small Cell Lung Cancer Developing After Regression of Clinically Suspected Methotrexate‐Associated Lymphoproliferative Disorder: A Diagnostic Pitfall in Rheumatoid Arthritis
Respirology Case Reports · 2026-11 · 14 (11)
DOI: 10.1002/rcr2.70831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology Case Reports, online erschienen am 12.11.2026. Verfasst von Takuma Nagayoshi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine Minami-Nara General Medical Center Nara Japan. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Methotrexate‐associated lymphoproliferative disorder (MTX‐LPD) is a complication of methotrexate therapy in patients with rheumatoid arthritis (RA). Distinguishing suspected MTX‐LPD from a new malignancy can be challenging when thoracic lesions appear after regression of earlier lesions. In a 69‐year‐old man with RA, MTX‐LPD was clinically suspected but not histopathologically confirmed during methotrexate therapy. Multiple pulmonary nodules, bilateral adrenal masses and an anterior chest wall lesion regressed after methotrexate withdrawal and corticosteroid therapy. Prednisolone was increased to prevent worsening of RA after methotrexate withdrawal. Approximately 15 months later, he presented with dyspnoea and chest computed tomography revealed multiple right pleural nodules, pleural thickening and pleural effusion. The pleural lesions differed in distribution from the initial abnormalities. Pleural fluid cytology suggested small cell carcinoma and computed tomography‐guided biopsy established a diagnosis of small cell lung cancer. Chemotherapy with carboplatin and etoposide resulted in tumour regression and reduced pleural effusion. This case emphasizes that regression following methotrexate withdrawal does not establish MTX‐LPD and that new or atypical thoracic lesions warrant renewed diagnostic assessment and tissue confirmation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine Minami-Nara General Medical Center Nara Japan.
- Department of Respiratory Medicine Nara Medical University Nara Japan.
- Department of Diagnostic Pathology Minami-Nara General Medical Center Nara Japan.
ORCID-Profile: Yoshiro Kai, Nobuhiro Fujioka, Kazuya Tanimura, Shigeo Muro
Zitieren
APA
Nagayoshi, T., Kai, Y., Takano, M., Suzuki, K., Osa, T., Harunari, K., Iwasa, Y., Fujioka, N., Ota, K., Kataoka, R., Furutaka, S., Furuyama, T., Miyataka, Y., Ibaraki, T., Tanimura, K., Yamamoto, Y., & Muro, S. (2026). Small Cell Lung Cancer Developing After Regression of Clinically Suspected Methotrexate‐Associated Lymphoproliferative Disorder: A Diagnostic Pitfall in Rheumatoid Arthritis. Respirology Case Reports, 14(11). https://doi.org/10.1002/rcr2.70831
Vancouver
Nagayoshi T, Kai Y, Takano M, Suzuki K, Osa T, Harunari K, et al. Small Cell Lung Cancer Developing After Regression of Clinically Suspected Methotrexate‐Associated Lymphoproliferative Disorder: A Diagnostic Pitfall in Rheumatoid Arthritis. Respirology Case Reports. 2026;14(11). doi:10.1002/rcr2.70831
BibTeX
@article{Nagayoshi2026,
author = {Nagayoshi, Takuma and Kai, Yoshiro and Takano, Masato and Suzuki, Kentaro and Osa, Takao and Harunari, Kanako and Iwasa, Yumi and Fujioka, Nobuhiro and Ota, Kazuki and Kataoka, Ryosuke and Furutaka, Shin and Furuyama, Tatsuhiro and Miyataka, Yasumasa and Ibaraki, Takahiro and Tanimura, Kazuya and Yamamoto, Yoshifumi and Muro, Shigeo},
title = {Small Cell Lung Cancer Developing After Regression of Clinically Suspected Methotrexate‐Associated Lymphoproliferative Disorder: A Diagnostic Pitfall in Rheumatoid Arthritis},
journal = {Respirology Case Reports},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/rcr2.70831}
}
EUVIMED